https://www.selleckchem.com/pr....oducts/telotristat-e
There were greater improvements in the PM group (n=16) vs. NPM group (n=1 for FEV1 (27.2 ± 6.0% vs. 3.9 ± 6.2%, p=0.017) and FVC (28.1 ± 5.3% vs. -0.5 ± 3.3%, p=0.001). There was no difference in ΔDLCO between groups. There were no differences between patients with PM and NPM in postoperative course/complications. No value for DHI predicted improvement in PFTs following DP. Patients with PM on sniff test have dramatically greater objective improvements in pulmonary function following plication than those
Like
Comment
Share
